Most people with Alzheimer's disease are never diagnosed.
There is no single diagnostic test for Alzheimer’s disease.
WHAT WE DO
A paradigm shift in our understanding of how Alzheimer's Disease manifests opens up a whole new way of diagnosing, treating and managing the disease.
Standalone Diagnostic
For Early-Stage Alzheimer's Disease
Precision Medicine
Personalized Treatment Plans
Measurement & Monitoring
Disease Progression
ESYA FOR ALZHEIMER'S
We develop early, precise and cost-effective diagnostic tools for presymptomatically diagnose Alzheimer’s disease
We combine patented intracellular analytics using DNA nanoprobes with AI to diagnose before symptoms manifest.
Precision medicine for Alzheimer's disease using patented DNA nanotechnology
Drugs are prescribed based on patient history, toxicology and on a trial and error basis. Esya’s platform enables quantitative measurement of individual response to drugs for personalised medicine.
Measuring Disease Progression
Ability to track disease progression over time.
Precision Diagnostics For Alzheimer's Disease Using Patented DNA Nanotechnology
“Most people with Alzheimer's disease are never diagnosed.” “There is no single diagnostic test for Alzheimer’s disease.“
ESYA FOR ALZHEIMER'S
We Develop Early, Precise, And Cost-Effective Diagnostic Tools For Neurodegenerative Diseases
We combine patented intracellular analytics using DNA nanoprobes with AI to diagnose before symptoms manifest.
A 360-Degree Perspective for Alzheimer's Disease based on Esya's patented DNA nanotechnology, unique biomarkers, and our multiomics platform
WHAT WE DO
A Paradigm Shift In How Alzheimer's Disease Manifests Opens Up A Whole New Way Of Diagnosing, Treating, And Managing The Disease
Standalone Diagnostic
For Early-Stage Alzheimer's Disease
Precision Medicine
Personalized Treatment Plans
Measurement & Monitoring
Disease Progression
If you crave challenges, there's no better place to be
Esya is a dynamic company operating at the intersection of biochemistry, technology and medicine. If you crave challenges and the chance to see your work impact the millions of lives touched by Alzheimer’s disease, there’s no better place to be.
